NCT00265291View on ClinicalTrials.gov

Antidepressant Treatment of Mexican-Americans: UCLA Pharmacogenetics and Pharmacogenomics Research Group

PHASE2CompletedINTERVENTIONAL
Enrollment

700

Participants

Timeline

Start Date

November 30, 1999

Primary Completion Date

May 31, 2006

Study Completion Date

October 31, 2008

Conditions
Major Depressive DisorderMajor DepressionUnipolar Depression
Interventions
DRUG

fluoxetine or desipramine

fluoxetine 5-40 mg/day desipramine 50-150 mg/day

Trial Locations (1)

33136

Center for Pharmacogenomics, University of Miami, Miami

All Listed Sponsors
lead

National Institute of General Medical Sciences (NIGMS)

NIH

NCT00265291 - Antidepressant Treatment of Mexican-Americans: UCLA Pharmacogenetics and Pharmacogenomics Research Group | Biotech Hunter | Biotech Hunter